Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

Boris Böll; Helen Goergen; Karolin Behringer; Paul J Bröckelmann; Felicitas Hitz; Andrea Kerkhoff; Richard Greil; Bastian von Tresckow; Dennis A Eichenauer; Carolin Bürkle; Sven Borchmann; Michael Fuchs; Volker Diehl; Andreas Engert; Peter Borchmann

doi:10.1182/blood-2015-11-681064

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

Boris Böll, Helen Goergen, Karolin Behringer, Paul J Bröckelmann, Felicitas Hitz, Andrea Kerkhoff, Richard Greil (Co-author), Bastian von Tresckow, Dennis A Eichenauer, Carolin Bürkle, Sven Borchmann, Michael Fuchs, Volker Diehl, Andreas Engert, Peter Borchmann

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

88 Citations (Web of Science)

Original language	English
Pages (from-to)	218-292
Journal	BLOOD
Volume	127
Issue number	18
DOIs	https://doi.org/10.1182/blood-2015-11-681064
Publication status	Published - 2016

Keywords

ELDERLY-PATIENTS
ABVD
VINBLASTINE
DACARBAZINE
ADRIAMYCIN
PREDNISONE
PHASE-2
REGIMEN
LINE

Access to Document

10.1182/blood-2015-11-681064

Cite this

Böll, B., Goergen, H., Behringer, K., Bröckelmann, P. J., Hitz, F., Kerkhoff, A., Greil, R., von Tresckow, B., Eichenauer, D. A., Bürkle, C., Borchmann, S., Fuchs, M., Diehl, V., Engert, A., & Borchmann, P. (2016). Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. BLOOD , 127(18), 218-292. https://doi.org/10.1182/blood-2015-11-681064

Böll, Boris ; Goergen, Helen ; Behringer, Karolin et al. / Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. In: BLOOD 2016 ; Vol. 127, No. 18. pp. 218-292.

@article{f701f9ee31744a559b3374024f79a41b,

title = "Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.",

keywords = "ELDERLY-PATIENTS, ABVD, VINBLASTINE, DACARBAZINE, ADRIAMYCIN, PREDNISONE, PHASE-2, REGIMEN, LINE",

author = "Boris B{\"o}ll and Helen Goergen and Karolin Behringer and Br{\"o}ckelmann, \{Paul J\} and Felicitas Hitz and Andrea Kerkhoff and Richard Greil and \{von Tresckow\}, Bastian and Eichenauer, \{Dennis A\} and Carolin B{\"u}rkle and Sven Borchmann and Michael Fuchs and Volker Diehl and Andreas Engert and Peter Borchmann",

note = "Greil: Third Medical Department, Paracelcus Medical University, Salzburg, Austria ",

year = "2016",

doi = "10.1182/blood-2015-11-681064",

language = "English",

volume = "127",

pages = "218--292",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "18",

}

Böll, B, Goergen, H, Behringer, K, Bröckelmann, PJ, Hitz, F, Kerkhoff, A, Greil, R, von Tresckow, B, Eichenauer, DA, Bürkle, C, Borchmann, S, Fuchs, M, Diehl, V, Engert, A & Borchmann, P 2016, 'Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.', BLOOD , vol. 127, no. 18, pp. 218-292. https://doi.org/10.1182/blood-2015-11-681064

Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. / Böll, Boris; Goergen, Helen; Behringer, Karolin et al.
In: BLOOD , Vol. 127, No. 18, 2016, p. 218-292.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

AU - Böll, Boris

AU - Goergen, Helen

AU - Behringer, Karolin

AU - Bröckelmann, Paul J

AU - Hitz, Felicitas

AU - Kerkhoff, Andrea

AU - Greil, Richard

AU - von Tresckow, Bastian

AU - Eichenauer, Dennis A

AU - Bürkle, Carolin

AU - Borchmann, Sven

AU - Fuchs, Michael

AU - Diehl, Volker

AU - Engert, Andreas

AU - Borchmann, Peter

N1 - Greil: Third Medical Department, Paracelcus Medical University, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - ELDERLY-PATIENTS

KW - ABVD

KW - VINBLASTINE

KW - DACARBAZINE

KW - ADRIAMYCIN

KW - PREDNISONE

KW - PHASE-2

KW - REGIMEN

KW - LINE

U2 - 10.1182/blood-2015-11-681064

DO - 10.1182/blood-2015-11-681064

M3 - Original Article

C2 - 26834240

SN - 0006-4971

VL - 127

SP - 218

EP - 292

JO - BLOOD

JF - BLOOD

IS - 18

ER -

Böll B, Goergen H, Behringer K, Bröckelmann PJ, Hitz F, Kerkhoff A et al. Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials. BLOOD . 2016;127(18):218-292. doi: 10.1182/blood-2015-11-681064